Filipec M, Letko E, Hasková Z, Jenícková D, Holler P, Jancárek A, Holán V
Second Department of Ophthalmology, First Medical Faculty, Charles University, Praha, Czech Republic.
Graefes Arch Clin Exp Ophthalmol. 1998 Jan;236(1):65-8. doi: 10.1007/s004170050044.
Urocanic acid (UCA) is a natural component of the stratum corneum of the skin. It has been described as a photoreceptor for ultraviolet B radiation. UCA is present in the skin as a trans-isomer and undergoes UVB irradiation-dependent isomerization from trans-to cis-isomer. An immunosuppressive effect of irradiated UCA, i.e. a mixture of cis- and trans-isomers, has been demonstrated both in vivo and in vitro. The aim of this study was to evaluate an immunosuppressive effect of irradiated UCA on graft rejection in an experimental model of orthotopic corneal transplantation.
A commercially available UCA was dissolved in salt solution and irradiated by XeCl excimer laser beam in order to obtain a mixture of cis- and trans-isomers. The immunosuppressive effect of irradiated UCA, compared to controls, unirradiated UCA and salt solution, was evaluated in a high-risk orthotopic corneal transplantation model; the agents were administered subconjunctivally to rabbits.
The rejection reaction was observed in all animals. The mean graft survival time in rabbits administered salt solution or unirradiated UCA was 20 days and 22 days, respectively. The irradiated solution of UCA significantly (P < 0.01, Mantel-Cox test) prolonged mean graft survival time to 29 days.
Subconjunctival administration of irradiated UCA prolonged the graft survival time in comparison with unirradiated UCA or salt solution in recipients in a rabbit transplantation model. Although further studies are necessary, UCA seems to be an effective immunosuppressive drug after corneal transplantation.
尿刊酸(UCA)是皮肤角质层的天然成分。它被描述为紫外线B辐射的光感受器。UCA以反式异构体的形式存在于皮肤中,并在紫外线B照射下发生从反式到顺式异构体的异构化。已在体内和体外证实了照射后的UCA(即顺式和反式异构体的混合物)具有免疫抑制作用。本研究的目的是在原位角膜移植实验模型中评估照射后的UCA对移植排斥反应的免疫抑制作用。
将市售的UCA溶解在盐溶液中,并用XeCl准分子激光束照射,以获得顺式和反式异构体的混合物。在高风险原位角膜移植模型中,与对照组、未照射的UCA和盐溶液相比,评估照射后的UCA的免疫抑制作用;将这些制剂结膜下注射给兔子。
在所有动物中均观察到排斥反应。给予盐溶液或未照射UCA的兔子的平均移植物存活时间分别为20天和22天。照射后的UCA溶液显著(P < 0.01,Mantel-Cox检验)将平均移植物存活时间延长至29天。
在兔移植模型中,与未照射的UCA或盐溶液相比,结膜下注射照射后的UCA延长了受体的移植物存活时间。尽管有必要进行进一步研究,但UCA似乎是角膜移植后一种有效的免疫抑制药物。